MANNARELLI, CARMELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.960
EU - Europa 2.179
AS - Asia 489
AF - Africa 11
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.947
RU - Federazione Russa 707
PL - Polonia 624
IT - Italia 341
IE - Irlanda 164
CN - Cina 152
SG - Singapore 128
SE - Svezia 115
HK - Hong Kong 90
CH - Svizzera 55
DE - Germania 44
FI - Finlandia 42
IN - India 39
JO - Giordania 34
GB - Regno Unito 25
FR - Francia 24
TW - Taiwan 17
CA - Canada 13
VN - Vietnam 12
BE - Belgio 10
CI - Costa d'Avorio 8
ES - Italia 8
AT - Austria 6
KR - Corea 6
CZ - Repubblica Ceca 5
IQ - Iraq 4
NL - Olanda 4
JP - Giappone 3
AE - Emirati Arabi Uniti 2
MU - Mauritius 2
RO - Romania 2
AL - Albania 1
AZ - Azerbaigian 1
BR - Brasile 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
MY - Malesia 1
SI - Slovenia 1
UA - Ucraina 1
Totale 5.642
Salva come PNG Salva come JPEG
Città #
Santa Clara 825
Warsaw 622
Fairfield 332
Chandler 197
Ashburn 183
Woodbridge 165
Dublin 164
Seattle 149
Houston 119
Wilmington 118
Cambridge 108
Ann Arbor 94
Singapore 90
Florence 85
Altamura 60
Beijing 58
Bern 55
Lawrence 55
Hong Kong 52
Princeton 48
Mumbai 32
Buffalo 31
Boston 30
Bremen 27
Shanghai 22
New York 21
San Diego 19
Helsinki 18
Kent 17
Boardman 15
Los Angeles 15
Taipei 14
Moscow 13
Rome 13
Dong Ket 12
Medford 11
Brussels 10
Abidjan 8
Barcelona 8
Falls Church 7
Fiesole 7
Toronto 7
Dearborn 6
London 6
Norwalk 6
Paris 6
Pian di Scò 6
Seoul 6
Vienna 6
Hillsboro 5
Jacksonville 5
Milan 5
Phoenix 5
Prague 5
Pune 5
Baghdad 4
Cagliari 4
Campi Bisenzio 4
Fuzhou 4
Montevarchi 4
Yubileyny 4
Andover 3
Brescia 3
Faenza 3
Falkenstein 3
Fontebuona 3
Guangzhou 3
Lappeenranta 3
Pavia 3
Reggio Emilia 3
Rimini 3
Rochester 3
Sesto Fiorentino 3
Villa Minozzo 3
Abu Dhabi 2
Bologna 2
Brest 2
Burghausen 2
Cantagallo 2
Chengdu 2
Chennai 2
Cortona 2
Ferrara 2
Gambettola 2
Genoa 2
Hefei 2
Jinan 2
Kilburn 2
Krasnoyarsk 2
Le Vigan 2
Livorno 2
Maranello 2
Munich 2
New Taipei 2
Padova 2
Pisa 2
Red Deer 2
Romainville 2
Sachigaoka 2
San Gavino Monreale 2
Totale 4.123
Salva come PNG Salva come JPEG
Nome #
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cells 273
Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms 273
Small RNA Sequencing Uncovers New miRNAs and moRNAs Differentially Expressed in Normal and Primary Myelofibrosis CD34+ Cells 237
“MiRNA expression in Primary Myelofibrosis: characterization and pathophysiology implications” 233
MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis 188
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 179
Spectrum of ASXL1 mutations in primary myelofibrosis: Prognostic impact of the ASXL1 p.G646Wfs∗12 mutation 163
Targeted deep sequencing in polycythemia vera and essential thrombocythemia 157
Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis 152
Mutations and prognosis in primary myelofibrosis. 150
Germline transmission of LNKE208Q variant in a family with myeloproliferative neoplasms 149
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 144
Clonal architecture of JAK2V617F mutated cells during treatment with ruxolitinib 143
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 140
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. 137
Safety and efficacy of ruxolitinib in splanchnic vein thrombosis associated with myeloproliferative neoplasms 136
Mutation landscape in patients with myelofibrosis receiving ruxolitinib or hydroxyurea 134
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in Primary Myelofibrosis 134
Involvement of RUNX1 Pathway Is a Common Event in the Leukemic Transformation of Chronic Myeloproliferative Neoplasms (MPNs) 133
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients 128
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 127
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis. 123
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 122
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients. 121
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia. 118
JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease 117
Novel insights into myelofibrosis pathophysiology and treatment 114
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features 109
Screening for Hereditary Alpha-Tryptasemia in Subjects with Systemic Mastocytosis (SM) and Non-SM Mast Cell Activation Symptoms 109
Calreticulin Mutation Is Associated with Milder Disease in Patients with Post Essential Thrombocythemia Myelofibrosis (PET-MF) Compared with JAK2V617F Mutation: A Study from the AGIMM Group 105
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 102
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells unveils the role of miR-155/JARID2 axis in abnormal megakaryopoiesis. 100
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 94
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations. 93
The ERCC2 Gln/Gln polymorphism at codon 751 is not associated with leukaemic transformation in primary myelofibrosis. 92
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis 90
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 87
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis 85
Clinical and molecular predictors of fibrotic progression in essential thrombocythemia: A multicenter study involving 1607 patients 82
Clinical, Molecular, and Histopathological Correlates in a Series of 24 Consecutive Cases of Suspected Myeloproliferative Neoplasms with a JAK2V617F Variant Allele Frequency≤ 1% 74
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera 65
Phenotypic correlations of CALR mutation variant allele frequency in patients with myelofibrosis 64
Disease correlates and clinical relevance of hereditary α-tryptasemia in patients with systemic mastocytosis 64
Diagnostic and therapeutic challenges in mast cell sarcoma 61
SF3B1 mutations in primary and secondary myelofibrosis: Clinical, molecular and prognostic correlates 48
Totale 5.749
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020593 0 0 0 0 0 111 105 119 90 71 83 14
2020/2021495 42 45 21 109 25 21 21 31 45 65 49 21
2021/2022315 4 17 36 8 16 19 9 41 11 16 52 86
2022/2023959 67 177 57 72 66 135 106 60 95 18 32 74
2023/2024471 25 35 61 22 51 55 18 113 11 21 38 21
2024/20251.915 72 249 161 426 670 337 0 0 0 0 0 0
Totale 5.749